Two steps forward in the treatment of colorectal cancer

被引：74

作者：

Mayer, RJ ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 23期

关键词：

D O I：

10.1056/NEJMe048098

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2406 / 2408

页数：3

共 18 条

[1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].

Andre, T ;

Boni, C ;

Mounedji-Boudiaf, L ;

Navarro, M ;

Tabernero, J ;

Hickish, T ;

Topham, C ;

Zaninelli, M ;

Clingan, P ;

Bridgewater, J ;

Tabah-Fisch, I ;

de Gramont, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351

[2]

CUNNINGHAM D, 2003, P AN M AM SOC CLIN, V22, P252

[3] Surrogate markers in antiangiogenesis clinical trials [J].

Davis, DW ;

McConkey, DJ ;

Abbruzzese, JL ;

Herbst, RS .

BRITISH JOURNAL OF CANCER, 2003, 89 (01) :8-14

[4] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[5]

Douillard JY, 2000, LANCET, V355, P1372

[6] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].

Douillard, JY ;

Cunningham, D ;

Roth, AD ;

Navarro, M ;

James, RD ;

Karasek, P ;

Jandik, P ;

Iveson, T ;

Carmichael, J ;

Alakl, M ;

Gruia, G ;

Awad, L ;

Rougier, P .

LANCET, 2000, 355 (9209) :1041-1047

[7] Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much? [J].

Gill, S ;

Loprinzi, CL ;

Sargent, DJ ;

Thomé, SD ;

Alberts, SR ;

Haller, DG ;

Benedetti, J ;

Francini, G ;

Shepherd, LE ;

Seitz, JF ;

Labianca, R ;

Chen, W ;

Cha, SS ;

Heldebrant, MP ;

Goldberg, RM .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1797-1806

[8] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[9] Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy [J].

Jain, RK .

NATURE MEDICINE, 2001, 7 (09) :987-989

[10] Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU) leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J].

Kabbinavar, F ;

Hurwitz, HI ;

Fehrenbacher, L ;

Meropol, NJ ;

Novotny, WF ;

Lieberman, G ;

Griffing, S ;

Bergsland, E .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :60-65

← 1 2 →